BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rieux-Laucat F, Magérus-Chatinet A, Neven B. The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions. J Clin Immunol 2018;38:558-68. [PMID: 29911256 DOI: 10.1007/s10875-018-0523-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Wallach-Dayan SB, Petukhov D, Ahdut-HaCohen R, Richter-Dayan M, Breuer R. sFasL-The Key to a Riddle: Immune Responses in Aging Lung and Disease. Int J Mol Sci 2021;22:2177. [PMID: 33671651 DOI: 10.3390/ijms22042177] [Reference Citation Analysis]
2 Dekeyser C, Naesens L, Offner F, De Vriendt C, Schauwvlieghe A, Kerre T, Laureys G. A unique phenotype of longitudinal extensive transverse myelitis in autoimmune lymphoproliferative syndrome. Journal of Neuroimmunology 2022. [DOI: 10.1016/j.jneuroim.2022.577866] [Reference Citation Analysis]
3 Anderton H, Wicks IP, Silke J. Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease. Nat Rev Rheumatol 2020;16:496-513. [PMID: 32641743 DOI: 10.1038/s41584-020-0455-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
4 Rossin A, Miloro G, Hueber AO. TRAIL and FasL Functions in Cancer and Autoimmune Diseases: Towards an Increasing Complexity. Cancers (Basel) 2019;11:E639. [PMID: 31072029 DOI: 10.3390/cancers11050639] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
5 Caron B, Patin E, Rotival M, Charbit B, Albert ML, Quintana-Murci L, Duffy D, Rausell A; Milieu Intérieur Consortium. Integrative genetic and immune cell analysis of plasma proteins in healthy donors identifies novel associations involving primary immune deficiency genes. Genome Med 2022;14:28. [PMID: 35264221 DOI: 10.1186/s13073-022-01032-y] [Reference Citation Analysis]
6 Mohan S, Mok S, Judge T. Identification of Novel Therapeutic Molecular Targets in Inflammatory Bowel Disease by Using Genetic Databases. Clin Exp Gastroenterol 2020;13:467-73. [PMID: 33116744 DOI: 10.2147/CEG.S264812] [Reference Citation Analysis]
7 Seyrek K, Ivanisenko NV, Wohlfromm F, Espe J, Lavrik IN. Impact of human CD95 mutations on cell death and autoimmunity: a model. Trends Immunol 2022;43:22-40. [PMID: 34872845 DOI: 10.1016/j.it.2021.11.006] [Reference Citation Analysis]
8 Suzuki T, Ichii O, Nakamura T, Horino T, Elewa YHA, Kon Y. Immune-associated renal disease found in caspase 3-deficient mice. Cell Tissue Res 2020;379:323-35. [PMID: 31440817 DOI: 10.1007/s00441-019-03084-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Lambert MP. Presentation and diagnosis of autoimmune lymphoproliferative syndrome (ALPS). Expert Rev Clin Immunol 2021;17:1163-73. [PMID: 34503378 DOI: 10.1080/1744666X.2021.1978842] [Reference Citation Analysis]
10 Oksenhendler E, Spaan AN, Neven B, Stolzenberg M, Fusaro M, Casanova J, Rieux-laucat F, Boisson B, Magérus A. Autoimmune Lymphoproliferative Syndrome Presenting with Invasive Streptococcus pneumoniae Infection. J Clin Immunol 2020;40:543-6. [DOI: 10.1007/s10875-020-00765-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Aresvik DM, Øverland T, Lima K, Pettersen RD, Abrahamsen TG. Lymphocyte Apoptosis and FAS Expression in Patients with 22q11.2 Deletion Syndrome. J Clin Immunol 2019;39:65-74. [PMID: 30569262 DOI: 10.1007/s10875-018-0579-7] [Reference Citation Analysis]
12 Consonni F, Gambineri E, Favre C. ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies. Ann Hematol. [DOI: 10.1007/s00277-022-04761-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Dell'Orso G, Grossi A, Penco F, Caorsi R, Palmisani E, Terranova P, Schena F, Lupia M, Ricci E, Montalto S, Pierri F, Ceccherini I, Fioredda F, Dufour C, Gattorno M, Miano M. Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure. Front Immunol 2021;12:754029. [PMID: 34721429 DOI: 10.3389/fimmu.2021.754029] [Reference Citation Analysis]
14 Kajikawa O, Herrero R, Chow YH, Hung CF, Matute-Bello G. The bioactivity of soluble Fas ligand is modulated by key amino acids of its stalk region. PLoS One 2021;16:e0253260. [PMID: 34138914 DOI: 10.1371/journal.pone.0253260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Trottier AM, Godley LA. Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities. Br J Haematol 2021;194:663-76. [PMID: 33615436 DOI: 10.1111/bjh.17247] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Huang X, Zhu J, Liu T, Li F, Yang T, Li H, Chen F, Zhang Y, Wang Y, Fu L, Xiao C, Geng D. Increased Expression of CD95 in CD4+ Effector Memory T Cells Promotes Th17 Response in Patients with Myasthenia Gravis. J Neuroimmune Pharmacol 2021. [PMID: 34716498 DOI: 10.1007/s11481-021-10030-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Funes SC, Ríos M, Gómez-Santander F, Fernández-Fierro A, Altamirano-Lagos MJ, Rivera-Perez D, Pulgar-Sepúlveda R, Jara EL, Rebolledo-Zelada D, Villarroel A, Roa JC, Mackern-Oberti JP, Kalergis AM. Tolerogenic dendritic cell transfer ameliorates systemic lupus erythematosus in mice. Immunology 2019;158:322-39. [PMID: 31509246 DOI: 10.1111/imm.13119] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
18 Perez Botero J, Di Paola J. Diagnostic approach to the patient with a suspected inherited platelet disorder: Who and how to test. J Thromb Haemost 2021;19:2127-36. [PMID: 34347927 DOI: 10.1111/jth.15484] [Reference Citation Analysis]
19 Magerus A, Bercher-Brayer C, Rieux-Laucat F. The genetic landscape of the FAS pathway deficiencies. Biomed J 2021:S2319-4170(21)00071-8. [PMID: 34171534 DOI: 10.1016/j.bj.2021.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Zhao EJ, Cheng CV, Mattman A, Chen LYC. Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management. Lancet Haematol 2021;8:e365-75. [PMID: 33894171 DOI: 10.1016/S2352-3026(21)00056-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Lu Y, Xi J, Zhang Y, Li C, Chen W, Hu X, Zhang M, Zhang F, Wei H, Li Z, Wang Z. MicroRNA-214-5p protects against myocardial ischemia reperfusion injury through targeting the FAS ligand. Arch Med Sci 2020;16:1119-29. [PMID: 32864001 DOI: 10.5114/aoms.2019.85405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
22 Gu Q, Hou W, Liu H, Shi L, Zhu Z, Ye W, Ni X. NUP210 and MicroRNA-22 Modulate Fas to Elicit HeLa Cell Cycle Arrest. Yonsei Med J 2020;61:371-81. [PMID: 32390360 DOI: 10.3349/ymj.2020.61.5.371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Notarangelo LD, Bacchetta R, Casanova JL, Su HC. Human inborn errors of immunity: An expanding universe. Sci Immunol 2020;5:eabb1662. [PMID: 32651211 DOI: 10.1126/sciimmunol.abb1662] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 18.0] [Reference Citation Analysis]
24 de Leval L. Approach to nodal-based T-cell lymphomas. Pathology 2020;52:78-99. [PMID: 31785821 DOI: 10.1016/j.pathol.2019.09.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
25 Walkovich K, Connelly JA. Understanding neutropenia secondary to intrinsic or iatrogenic immune dysregulation. Hematology Am Soc Hematol Educ Program 2021;2021:504-13. [PMID: 34889406 DOI: 10.1182/hematology.2021000285] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Casanova J, Bonagura V. Editorial, Journal of Clinical Immunology. J Clin Immunol 2019;39:751-2. [DOI: 10.1007/s10875-019-00699-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Casamayor-Polo L, López-Nevado M, Paz-Artal E, Anel A, Rieux-Laucat F, Allende LM. Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS). Crit Rev Clin Lab Sci 2021;58:253-74. [PMID: 33356695 DOI: 10.1080/10408363.2020.1855623] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
28 Papadopoulou AA, Fluhrer R. Signaling Functions of Intramembrane Aspartyl-Proteases. Front Cardiovasc Med 2020;7:591787. [PMID: 33381526 DOI: 10.3389/fcvm.2020.591787] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Haas OA. Primary Immunodeficiency and Cancer Predisposition Revisited: Embedding Two Closely Related Concepts Into an Integrative Conceptual Framework. Front Immunol 2018;9:3136. [PMID: 30809233 DOI: 10.3389/fimmu.2018.03136] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
30 Schmitz J, Böhm M. Is Fas-mediated apoptosis of melanocytes indispensable in vitiligo? Exp Dermatol 2021. [PMID: 34396580 DOI: 10.1111/exd.14448] [Reference Citation Analysis]
31 Mitsuiki N, Schwab C, Grimbacher B. What did we learn from CTLA-4 insufficiency on the human immune system? Immunol Rev 2019;287:33-49. [PMID: 30565239 DOI: 10.1111/imr.12721] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 15.0] [Reference Citation Analysis]
32 López-Nevado M, Docampo-Cordeiro J, Ramos JT, Rodríguez-Pena R, Gil-López C, Sánchez-Ramón S, Gil-Herrera J, Díaz-Madroñero MJ, Delgado-Martín MA, Morales-Pérez P, Paz-Artal E, Magerus A, Rieux-Laucat F, Allende LM. Next Generation Sequencing for Detecting Somatic FAS Mutations in Patients With Autoimmune Lymphoproliferative Syndrome. Front Immunol 2021;12:656356. [PMID: 33995372 DOI: 10.3389/fimmu.2021.656356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Yamashita M, Inoue K, Okano T, Morio T. Inborn errors of immunity-recent advances in research on the pathogenesis. Inflamm Regen 2021;41:9. [PMID: 33766139 DOI: 10.1186/s41232-021-00159-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]